LENZ
LENZ Therapeutics
LENZ
LENZ
67 hedge funds and large institutions have $75.8M invested in LENZ Therapeutics in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.15% less ownership
Funds ownership: 7.68% → 7.53% (-0.15%)
7% less capital invested
Capital invested by funds: $81.2M → $75.8M (-$5.47M)
Holders
67
Holding in Top 10
2
Calls
$2K
Puts
$1K
Top Buyers
| 1 | +$1.35M | |
| 2 | +$235K | |
| 3 | +$184K | |
| 4 |
Millennium Management
New York
|
+$147K |
| 5 |
CCM
Corsair Capital Management
New York
|
+$114K |
Top Sellers
| 1 | -$1.06M | |
| 2 | -$898K | |
| 3 | -$596K | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$519K |
| 5 |
WSL
Western Standard LLC
Los Angeles,
California
|
-$455K |